Dr Shevanthi Nayagam is a Consultant Hepatologist and Clinical Academic at Imperial College London. Her research, to date, has focused on combining clinical field epidemiology, applied modelling and health economics in guiding public health policy towards the elimination of viral hepatitis, with a focus on low-and middle-income countries.
She is a research member of the PROLIFICA team (Prevention of Liver Disease and Cancer in Africa) and has worked with many countries to support their national hepatitis strategies. Since 2012 she has also worked with WHO in various advisory roles (including guidelines development) and is a member of the Vaccine Impact Modelling Consortium
